NCT02104076

Evolution® Biliary Stent System-Fully Covered

Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Cook Group Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.

Conditions

• Carcinomas/Neoplasms

Interventions

Type	Name	Description
DEVICE	Evolution® Biliary Stent-Fully Covered	Implantation of the Evolution® Biliary Stent-Fully Covered in the common bile duct utilizing ERCP

Timeline

• Start date: 2014-09-01
• Primary completion: 2016-07-01
• Completion: 2017-01-04
• First posted: 2014-04-04
• Last updated: 2017-07-05

Locations

12 sites across 4 countries: United States, Canada, France, Netherlands